Disclosure:
(view policy)
|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 8 March 2007]
The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled “Methods for Labeling -Amyloid Plaques and Neurofibrillary Tangles,” which has been licensed to Siemens. Dr. Small is among the inventors, has received royalties, and will receive royalties on future sales. Dr. Small reports having served as a consultant and/or having received lecture fees from Abbott, Brainstorming Co., Dakim, Eisai, Forest, Myriad Genetics, Novartis, Ortho-McNeil, Pfizer, Radica, Servier, and Siemens. Dr. Small also reports having received stock options from Dakim and having received a grant from GlaxoSmithKline.
|
Home
